Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases (ACT-AD)

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 7, 2025

Primary Completion Date

March 10, 2026

Study Completion Date

April 10, 2026

Conditions
Alzheimer DiseaseTranscranial Magnetic StimulationCerebellum
Interventions
DEVICE

Intermittent Theta-Burst Transcranial Magnetic Stimulation

50Hz, stimulation intensity of 100% RMT, duration of 40s as a group of stimulation, 600 stimulation pulses, repeated stimulation of bilateral cerebellar dentate nuclei, with a 5-minute interval between each group, 1200 stimulation pulses per site, 5 times a week, treatment for 4 weeks, then treat once a week for 8 weeks.

Trial Locations (2)

710032

RECRUITING

Xijing Hospital of Air Force Military Medical University, Xi'an

RECRUITING

Xijing Hospital of Air Force Military Medical University, Xi'an

All Listed Sponsors
collaborator

Tang-Du Hospital

OTHER

collaborator

The Third Hospital of Xi'an

UNKNOWN

collaborator

First Affiliated Hospital Xi'an Jiaotong University

OTHER

lead

Xijing Hospital

OTHER